Lymphangioleiomyomatosis - Calling it what it is: A low-grade, destructive, metastasizing neoplasm

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 12, 2012, Pages 1210-1212

  McCormack, Francis X ^a   Travis, William D ^b   Colby, Thomas V ^c   Henske, Elizabeth P ^d   Moss, Joel ^e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MAYO CLINIC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; PROGESTERONE; TUBERIN;

ANGIOGENESIS; CANCER CELL; CANCER GRADING; CELL INVASION; CELL METABOLISM; CELL PROLIFERATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; LUNG INFILTRATE; LUNG INJURY; LYMPHANGIOGENESIS; LYMPHANGIOLEIOMYOMATOSIS; LYMPHATIC SYSTEM; MALIGNANT TRANSFORMATION; MENSTRUAL CYCLE; METASTASIS; METASTASIS POTENTIAL; PATIENT DECISION MAKING; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; TUBEROUS SCLEROSIS; TUMOR CLASSIFICATION;

CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; NEOPLASM METASTASIS;

EID: 84871731680     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201205-0848OE     Document Type: Review

References (28)

1. Travis WD, Brambilla E, Muller-Hermlink HK, Harris CC. Pathology and genetics: tumours of the lung, pleura, thymus and heart. Lyon: IARC; 2004.
2. Travis WD, Colby TV, Corrin B, Shumosato Y, Brambilla E; in collaboration with L. H. Sobin and pathologists from fourteen countries. Histological typing of lung and pleural tumors. Berlin: Springer; 1999.
3. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2000;97:6085-6090. (Pubitemid 30367527)
4. Henske EP. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosomes Cancer 2003;38:376-381. (Pubitemid 37466939)
5. Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, Ferrans VJ, Moss J. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999;115:1041-1052. (Pubitemid 29193675)
6. Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, Moss J, Ferrans VJ. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy: an immunohistochemical study. Am J Respir Crit Care Med 2000;161:1002-1009. (Pubitemid 30171764)
7. Sandrini A, Silverstone E, Yates DH. Menstrual cycle variation of retroperitoneal lymphangioleiomyomas in lymphangioleiomyomatosis. Intern Med J 2011;41:832-835.
8. Hayashi T, Kumasaka T, Mitani K, Terao Y, Watanabe M, Oide T, Nakatani Y, Hebisawa A, Konno R, Takahashi K, et al. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients. Am J Surg Pathol 2011;35:1776-1785.
9. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005;37:19-24. (Pubitemid 40070934)
10. Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, Yeung RS, Walker CL, Noonan D, Kwiatkowski DJ, Chou MM, et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 2002;277:30958-30967. (Pubitemid 34970798)
11. Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, McCormack FX, Henske EP. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 2003;167:976-982. (Pubitemid 36408163)
12. Bittmann I, Rolf B, Amann G, Lohrs U. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol 2003;34:95-98. (Pubitemid 36160028)
13. Cai X, Pacheco-Rodriguez G, Fan QY, Haughey M, Samsel L, El-Chemaly S, Wu HP, McCoy JP, Steagall WK, Lin JP, et al. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis. Am J Respir Crit Care Med 2010;182:1410-1418.
14. Goncharova EA, Goncharov DA, Lim PN, Noonan D, Krymskaya VP. Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 2006;34:473-480.
15. Sun Q, Chen X, Ma J, Peng H, Wang F, Zha X, Wang Y, Jing Y, Yang H, Chen R, et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci USA 2011;108:4129-4134.
16. Kumasaka T, Seyama K, Mitani K, Sato T, Souma S, Kondo T, Hayashi S, Minami M, Uekusa T, Fukuchi Y, et al. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol 2004;28:1007-1016. (Pubitemid 38971424)
17. Kumasaka T, Seyama K, Mitani K, Souma S, Kashiwagi S, Hebisawa A, Sato T, Kubo H, Gomi K, Shibuya K, et al. Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol 2005;29:1356-1366. (Pubitemid 41368772)
18. Valensi QJ. Pulmonary lymphangiomyoma, a probable forme frust of tuberous sclerosis: a case report and survey of the literature. Am Rev Respir Dis 1973;108:1411-1415.
19. Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy JP Jr, Wang JA, Kumaki F, Darling T, Moss J. Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2004;101:17462-17467. (Pubitemid 39657427)
20. Hayashi T, Fleming MV, Stetler-Stevenson WG, Liotta LA, Moss J, Ferrans VJ, Travis WD. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis. Hum Pathol 1997;28:1071-1078. (Pubitemid 27388109)
21. Chilosi M, Pea M, Martignoni G, Brunelli M, Gobbo S, Poletti V, Bonetti F. Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. Mod Pathol 2009;22:161-166.
22. Henske EP, McCormack FX. Lymphangioleiomyomatosis - a wolf in sheep's clothing. J Clin Invest 2012;122:3807-3816.
23. Oprescu N, McCormack FX, Byrnes S, Kinder BW. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry. Lung (In press)
24. Bowen JM, Cates JM, Kash S, Itani D, Gonzalez A, Huang D, Oliveira A, Bridge JA. Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet 2012;205:249-254.
25. NCI. NCI dictionary of cancer terms. 2012 [accessed 2012 Aug 16]. Available from: http://www.cancer.gov/dictionary?cdrid=45771
26. WHO. WHO cancer definition. 2012 [accessed 2012 Aug 16]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/index.html
27. Chabner BA, Smith M. Call it cancer. Oncologist 2012;17:149-150.
28. McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011;364:1595-1606.